tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Pliant Therapeutics Inc

PLRX
Add to Watchlist
1.090USD
+0.010+0.93%
Close 07-24 16:00（ET）Quotes delayed by 15 min
67.49MMarket Cap
LossP/E TTM

Pliant Therapeutics Inc

1.090
+0.010+0.93%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

PLRX Financials

See Pliant Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Pliant Therapeutics Inc Earnings Date

Latest Release
May 11, 2026
EPS / Forecast
-0.32/-0.36
Revenue / Forecast
--/0.00
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-2.43
29.94%
Analyst Rating
HOLD
2026/07/26
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
64.66%-0.32
53.05%-0.38
54.97%-0.43
23.74%-0.71
-17.58%-0.92
-19.11%-0.82
-36.84%-0.95
-32.88%-0.93
-16.49%-0.78
4.39%-0.69
---0.70
---0.70
---0.67
---0.72
---2.22
----
----
----
----
----
Revenue
----
----
----
--0.00
--0.00
--0.00
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-95.03%248.00K
6.65%1.33M
-1.70%1.96M
-7.95%1.48M
178.87%4.99M
-42.55%1.25M
-55.23%2.00M
-66.56%1.61M
-50.31%1.79M
Net Profit
64.32%-20.04M
52.59%-23.58M
54.47%-26.30M
22.48%-43.30M
-19.62%-56.17M
-20.98%-49.73M
-39.23%-57.76M
-35.59%-55.85M
-25.05%-46.95M
-17.25%-41.11M
-35.51%-41.49M
-39.42%-41.19M
-33.62%-37.55M
-42.92%-35.06M
-13.20%-30.61M
-29.41%-29.55M
-22.94%-28.10M
-28.93%-24.53M
-63.57%-27.05M
-34.29%-22.83M
Net Margin
----
----
----
----
----
----
----
----
----
----
----
---16609.68%
---2818.92%
---1784.22%
---1143.28%
----
----
----
----
----
Gross Margin
----
----
----
----
----
----
----
----
----
----
----
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
Debt to assets ratio
-100.00%0.00%
-100.00%0.00%
62.73%11.00%
62.89%10.13%
52.71%8.78%
287.70%7.61%
264.73%6.76%
257.80%6.22%
245.34%5.75%
-30.68%1.96%
--1.85%
--1.74%
--1.67%
--2.83%
--2.62%
----
----
----
----
----
Income Statement
Revenue
----
----
----
--0.00
--0.00
--0.00
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-95.03%248.00K
6.65%1.33M
-1.70%1.96M
-7.95%1.48M
178.87%4.99M
-42.55%1.25M
-55.23%2.00M
-66.56%1.61M
-50.31%1.79M
Operating profit
63.06%-21.77M
55.78%-23.58M
54.58%-28.17M
30.92%-41.89M
-12.49%-58.94M
-13.36%-53.32M
-30.05%-62.01M
-28.13%-60.64M
-24.46%-52.39M
-25.77%-47.04M
-49.26%-47.69M
-59.67%-47.33M
-49.21%-42.09M
-52.04%-37.40M
-17.83%-31.95M
-29.42%-29.64M
-23.09%-28.21M
-29.36%-24.60M
-62.73%-27.11M
-34.92%-22.90M
Net Profit
64.32%-20.04M
52.59%-23.58M
54.47%-26.30M
22.48%-43.30M
-19.62%-56.17M
-20.98%-49.73M
-39.23%-57.76M
-35.59%-55.85M
-25.05%-46.95M
-17.25%-41.11M
-35.51%-41.49M
-39.42%-41.19M
-33.62%-37.55M
-42.92%-35.06M
-13.20%-30.61M
-29.41%-29.55M
-22.94%-28.10M
-28.93%-24.53M
-63.57%-27.05M
-34.29%-22.83M
Balance Sheet
Current assets
-43.79%174.93M
-45.77%196.45M
-40.11%245.59M
-40.24%267.44M
-36.48%311.19M
-28.34%362.26M
-23.26%410.03M
-20.89%447.55M
-16.72%489.90M
48.54%505.50M
46.01%534.34M
226.00%565.70M
217.34%588.23M
62.49%340.31M
60.10%365.96M
-30.79%173.53M
-31.48%185.36M
-27.97%209.44M
-25.72%228.58M
-22.69%250.72M
Total current liabilities
-63.27%10.36M
-50.73%16.36M
-55.89%17.62M
-33.41%20.59M
-7.20%28.20M
16.46%33.22M
45.84%39.95M
4.76%30.92M
31.26%30.39M
19.28%28.52M
4.72%27.39M
30.89%29.52M
26.46%23.15M
42.08%23.91M
102.41%26.16M
106.30%22.55M
78.62%18.31M
45.11%16.83M
17.22%12.93M
-9.17%10.93M
Total assets
-41.24%202.60M
-43.26%225.23M
-37.94%276.60M
-38.02%299.82M
-33.90%344.77M
-22.49%396.95M
-17.54%445.67M
-15.86%483.73M
-12.76%521.61M
46.07%512.15M
43.29%540.46M
211.39%574.89M
203.46%597.88M
58.49%350.61M
61.11%377.18M
-27.80%184.62M
-28.42%197.02M
-25.15%221.22M
-25.04%234.12M
-22.23%255.72M
Total liabilities
-57.27%37.43M
-52.60%44.02M
-23.59%76.29M
-12.42%79.74M
3.96%87.61M
140.73%92.87M
166.85%99.84M
117.69%91.05M
134.35%84.27M
3.51%38.58M
-6.90%37.42M
13.56%41.83M
54.81%35.96M
68.22%37.27M
193.74%40.19M
213.83%36.83M
109.55%23.23M
77.75%22.16M
14.22%13.68M
-9.63%11.74M
Total equity
-35.77%165.17M
-40.41%181.21M
-42.08%200.31M
-43.95%220.08M
-41.20%257.16M
-35.79%304.08M
-31.25%345.82M
-26.34%392.68M
-22.17%437.33M
51.14%473.58M
49.28%503.05M
260.70%533.07M
223.33%561.92M
57.41%313.34M
52.87%336.99M
-39.43%147.79M
-34.21%173.79M
-29.68%199.06M
-26.60%220.44M
-22.75%243.98M
Cash Flow Statement
Net operating income
60.65%-19.23M
62.68%-17.79M
34.68%-21.08M
10.36%-40.60M
-61.42%-48.86M
-89.87%-47.66M
10.91%-32.27M
-82.95%-45.30M
0.02%-30.27M
19.65%-25.10M
-95.83%-36.22M
-1.49%-24.76M
-47.70%-30.28M
-57.26%-31.24M
17.82%-18.50M
-25.73%-24.40M
-50.00%-20.50M
-20.50%-19.86M
-42.54%-22.51M
-349.65%-19.40M
Net investment
-105.93%-4.10M
-95.48%1.77M
-9.82%27.92M
231.59%35.49M
16.07%69.11M
22.59%39.13M
-19.07%30.96M
146.57%10.70M
134.18%59.55M
59.43%31.92M
121.46%38.25M
-453.78%-22.98M
-11478.71%-174.21M
-22.34%20.02M
-655.30%-178.25M
81.22%6.50M
-87.48%1.53M
116.55%25.78M
130.55%32.10M
103.37%3.58M
Net financing
-85.14%74.00K
-31734.31%-32.27M
-86.74%72.00K
-100.00%0.00
-97.71%498.00K
-53.42%102.00K
-22.32%543.00K
324.84%684.00K
-92.03%21.79M
-22.89%219.00K
-99.68%699.00K
-98.46%161.00K
178744.44%273.33M
-44.96%284.00K
48073.05%216.30M
5330.21%10.43M
-111.17%-153.00K
117.72%516.00K
118.99%449.00K
-99.88%192.00K

FAQs

What are the current assets of Pliant Therapeutics Inc?

According to Pliant Therapeutics Inc's FY2025 earnings report, its current assets were 196.45M, with a year-on-year change of -45.77.

What are the total assets of Pliant Therapeutics Inc?

According to Pliant Therapeutics Inc's FY2025 earnings report, its total assets of Pliant Therapeutics Inc were 225.23M, with a year-on-year change of -43.26.

What are the total liabilities of Pliant Therapeutics Inc?

According to Pliant Therapeutics Inc's FY2025 earnings report, its total liabilities of Pliant Therapeutics Inc were 44.02M, with a year-on-year change of -52.60.

What is the total equity of Pliant Therapeutics Inc?

According to Pliant Therapeutics Inc's FY2025 earnings report, its total equity of Pliant Therapeutics Inc was 181.21M, with a year-on-year change of -40.41.

What is the net operating income of Pliant Therapeutics Inc?

According to Pliant Therapeutics Inc's FY2025 earnings report, its net operating income of Pliant Therapeutics Inc was -152.57M, with a year-on-year change of 33.19.

What is the net investment of Pliant Therapeutics Inc?

According to Pliant Therapeutics Inc's FY2025 earnings report, its net investment of Pliant Therapeutics Inc was 134.29M, with a year-on-year change of -4.31.

What is the net financing of Pliant Therapeutics Inc?

According to Pliant Therapeutics Inc's FY2025 earnings report, its net financing of Pliant Therapeutics Inc was -31.70M, with a year-on-year change of -237.12.

What is the Earnings Per Share (EPS) of Pliant Therapeutics Inc?

According to Pliant Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -2.43, with a year-on-year change of 29.94.

What is the net income of Pliant Therapeutics Inc?

According to Pliant Therapeutics Inc's FY2025 earnings report, its net income was -149.34M, with a year-on-year change of 28.99.

What is the Return on Equity (ROE) of Pliant Therapeutics Inc?

According to Pliant Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -61.55, with a year-on-year change of -13.80.

What is the Return on Assets (ROA) of Pliant Therapeutics Inc?

According to Pliant Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -48.01, with a year-on-year change of -3.76.

What is the operating profit of Pliant Therapeutics Inc?

According to Pliant Therapeutics Inc's FY2025 earnings report, its operating profit was -152.57M, with a year-on-year change of 33.19.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy